Abstract
Objective
Even though all guidelines recommend generally against antipsychotic polypharmacy, antipsychotic polypharmacy appears to be a very common practice across the globe. This study aimed to examine the prescription patterns of antipsychotics in Qatar, in comparison with the international guidelines, and to scrutinize the sociodemographic and clinical features associated with antipsychotic polypharmacy.
Methods
All the medical records of all the inpatients and outpatients treated by antipsychotics at the Department of Psychiatry–Hamad Medical Corporation (HMC) in Doha, Qatar (between October 2012 and April 2014) were retrospectively analyzed. We retrieved the available sociodemographic data, psychiatric features, and details on the medication history.
Results
Our sample consisted of 537 individuals on antipsychotics (2/3 were male; mean age 33.8±10.2 years), prescribed for a psychotic disorder in 57%, a mood disorder in 9.3%, and various other diagnoses in 33.7%. About 55.9% received one antipsychotic, 29.6% received two antipsychotics, and 14.5% received more than two antipsychotics. Polypharmacy was associated with younger age (p = 0.025), being single (p<0.001), the diagnosis of a psychotic disorder (p<0.001), and previous admissions to psychiatry (p<0.001).
Conclusions
Antipsychotic polypharmacy appears to be quite common in Qatar, as it is the case in many other countries, in contrast with most international recommendations. Studies are needed to explore the reasons behind this disparity.
Funder
Qatar National Research Fund
Publisher
Public Library of Science (PLoS)
Reference31 articles.
1. A systematic review of clinical guidelines on choice, dose, and duration of antipsychotics treatment in first- and multi-episode schizophrenia;CLM Hui;International review of psychiatry
2. Guidelines for the Pharmacotherapy of Schizophrenia in Adults.;G Remington;Canadian journal of psychiatry Revue canadienne de psychiatrie,2017
3. Antipsychotic polypharmacy: squandering precious resources;SM Stahl;The Journal of clinical psychiatry,2002
4. "First do no harm." A systematic review of the prevalence and management of antipsychotic adverse effects;SL Young;Journal of psychopharmacology,2015
5. Schizophrenia, neuroleptic medication and mortality;M Joukamaa;The British journal of psychiatry: the journal of mental science,2006
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献